Skip to content

Clinical trials

Phase 3 Graft vs Host Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Phase: Phase 3 Clear all

65 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20023
20031
20044
20053
20063
20073
20085
20092
20103
20111
20122
20131
20141
20161
20175
20183
20191
20201
20211
20223
20232
20241
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Terminated10
Recruiting4
Unknown status4
Not yet recruiting2
Withdrawn2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hadassah Medical Organization3
Incyte Corporation3
Novartis Pharmaceuticals3
Wyeth is now a wholly owned subsidiary of Pfizer3
Assistance Publique - Hôpitaux de Paris2
Children's Oncology Group2
Dana-Farber Cancer Institute2
Fred Hutchinson Cancer Center2
Mesoblast, Inc.2
Shanghai Jiao Tong University School of Medicine2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease65
Precursor Cell Lymphoblastic Leukemia-Lymphoma14
Leukemia, Myeloid, Acute11
Leukemia9
Myelodysplastic Syndromes9
Lymphoma, Non-Hodgkin8
Hodgkin Disease7
Leukemia, Lymphocytic, Chronic, B-Cell7
Lymphoma7
Burkitt Lymphoma6

Trials

Showing 51 to 65 of 65. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.